The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Checkpoint Therapeutics Inc (NASDAQ: CKPT) closed the day trading at $4.02 up 0.25% from the previous closing price of $4.01. In other words, the price has increased by $0.25 from its previous closing price. On the day, 1.05 million shares were traded. CKPT stock price reached its highest trading level at $4.035 during the session, while it also had its lowest trading level at $4.01.
Ratios:
For a better understanding of CKPT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.37 and its Current Ratio is at 0.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on January 13, 2025, initiated with a Buy rating and assigned the stock a target price of $9.
On June 09, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $18.B. Riley Securities initiated its Buy rating on June 09, 2021, with a $18 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’25 when Oliviero James F III sold 15,090 shares for $4.04 per share. The transaction valued at 60,964 led to the insider holds 3,759,929 shares of the business.
GRAY WILLIAM GARRETT sold 12,322 shares of CKPT for $49,904 on Apr 01 ’25. The Chief Financial Officer now owns 1,446,322 shares after completing the transaction at $4.05 per share. On Feb 10 ’25, another insider, Oliviero James F III, who serves as the CEO, President and Director of the company, sold 10,331 shares for $3.15 each. As a result, the insider received 32,543 and left with 3,775,019 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CKPT now has a Market Capitalization of 336730048 and an Enterprise Value of 330126208. For the stock, the TTM Price-to-Sale (P/S) ratio is 8418.19. Its current Enterprise Value per Revenue stands at 8051.859.
Stock Price History:
The Beta on a monthly basis for CKPT is 1.17, which has changed by 1.4071856 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, CKPT has reached a high of $4.50, while it has fallen to a 52-week low of $1.38. The 50-Day Moving Average of the stock is 12.77%, while the 200-Day Moving Average is calculated to be 31.63%.
Shares Statistics:
Over the past 3-months, CKPT traded about 2.64M shares per day on average, while over the past 10 days, CKPT traded about 2514010 shares per day. A total of 83.76M shares are outstanding, with a floating share count of 62.05M. Insiders hold about 25.93% of the company’s shares, while institutions hold 24.07% stake in the company. Shares short for CKPT as of 1743379200 were 5028257 with a Short Ratio of 1.91, compared to 1740700800 on 7154701. Therefore, it implies a Short% of Shares Outstanding of 5028257 and a Short% of Float of 6.52.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
